Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Nab-Paclitaxel+Cisplatin+Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
A Phase 1b/2 Pilot Trial of Nab-Paclitaxel Plus Cisplatin Plus Gemcitabine (Nabplagem) in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
Status: Enrolling
Updated:  2/27/2014
Scottsdale Health Care
mi
from
Scottsdale, AZ
Nab-Paclitaxel+Cisplatin+Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
A Phase 1b/2 Pilot Trial of Nab-Paclitaxel Plus Cisplatin Plus Gemcitabine (Nabplagem) in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
Status: Enrolling
Updated: 2/27/2014
Scottsdale Health Care
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Nab-Paclitaxel+Cisplatin+Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
A Phase 1b/2 Pilot Trial of Nab-Paclitaxel Plus Cisplatin Plus Gemcitabine (Nabplagem) in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
Status: Enrolling
Updated:  2/27/2014
Rutgers Cancer Institute of New Jersey (CINJ)
mi
from
New Brunswick, NJ
Nab-Paclitaxel+Cisplatin+Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
A Phase 1b/2 Pilot Trial of Nab-Paclitaxel Plus Cisplatin Plus Gemcitabine (Nabplagem) in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
Status: Enrolling
Updated: 2/27/2014
Rutgers Cancer Institute of New Jersey (CINJ)
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Nab-Paclitaxel+Cisplatin+Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
A Phase 1b/2 Pilot Trial of Nab-Paclitaxel Plus Cisplatin Plus Gemcitabine (Nabplagem) in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
Status: Enrolling
Updated:  2/27/2014
Vita Medical Associates P.C.
mi
from
Bethlehem, PA
Nab-Paclitaxel+Cisplatin+Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
A Phase 1b/2 Pilot Trial of Nab-Paclitaxel Plus Cisplatin Plus Gemcitabine (Nabplagem) in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
Status: Enrolling
Updated: 2/27/2014
Vita Medical Associates P.C.
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Nanocytology Test to Evaluate Skin Cancer in High Risk Patients
Nanocytology Evaluation of Epidermal Cells to Assess Risk of Squamous Cell Carcinoma and Field Cancerization in High Risk Patients
Status: Enrolling
Updated:  2/27/2014
Northwestern Memorial Hospital
mi
from
Chicago, IL
Nanocytology Test to Evaluate Skin Cancer in High Risk Patients
Nanocytology Evaluation of Epidermal Cells to Assess Risk of Squamous Cell Carcinoma and Field Cancerization in High Risk Patients
Status: Enrolling
Updated: 2/27/2014
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Status: Enrolling
Updated:  3/4/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Status: Enrolling
Updated: 3/4/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Pilot Study of Working Women and Breast Cancer
A Pilot Study of Working Women and Breast Cancer
Status: Enrolling
Updated:  3/4/2014
UK Center for Clinical and Translational Science
mi
from
Lexington, KY
A Pilot Study of Working Women and Breast Cancer
A Pilot Study of Working Women and Breast Cancer
Status: Enrolling
Updated: 3/4/2014
UK Center for Clinical and Translational Science
mi
from
Lexington, KY
Click here to add this to my saved trials
A Pilot Study of Working Women and Breast Cancer
A Pilot Study of Working Women and Breast Cancer
Status: Enrolling
Updated:  3/4/2014
University of Kentucky, Markey Cancer Center
mi
from
Lexington, KY
A Pilot Study of Working Women and Breast Cancer
A Pilot Study of Working Women and Breast Cancer
Status: Enrolling
Updated: 3/4/2014
University of Kentucky, Markey Cancer Center
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Baltimore, MD
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Detroit, MI
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Chattanooga, TN
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Houston, TX
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Fountain Valley, CA
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Oxnard, CA
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Oxnard, CA
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Chicago, IL
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Lafayette, IN
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Lafayette, IN
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Baton Rouge, LA
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Annapolis, MD
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Annapolis, MD
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Boston, MA
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Danvers, MA
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Danvers, MA
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Omaha, NE
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Lake Success, NY
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Lake Success, NY
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Canton, OH
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Canton, OH
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Dover, OH
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Dover, OH
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Hershey, PA
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Hershey, PA
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Research Site
mi
from
Hilton Head, SC
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Research Site
mi
from
Hilton Head, SC
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
Clinical Research Facility
mi
from
Corpus Christi, TX
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
Clinical Research Facility
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/5/2014
mi
from
Ottawa,
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/5/2014
mi
from
Ottawa,
Click here to add this to my saved trials
Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia
Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia
Status: Enrolling
Updated:  3/10/2014
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia
Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia
Status: Enrolling
Updated: 3/10/2014
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Tablet vs. Liquid Suspension Ibuprofen in the Relief of Pain
Tablet vs. Liquid Suspension Ibuprofen in the Relief of Pain
Status: Enrolling
Updated:  3/10/2014
Albany Medical Center Emergency Department
mi
from
Albany, NY
Tablet vs. Liquid Suspension Ibuprofen in the Relief of Pain
Tablet vs. Liquid Suspension Ibuprofen in the Relief of Pain
Status: Enrolling
Updated: 3/10/2014
Albany Medical Center Emergency Department
mi
from
Albany, NY
Click here to add this to my saved trials
New Individualized Therapy Trial for Metastatic Colorectal Cancer
A Phase I/II Study of Gleevec® Combined With Panitumumab (Vectibix®) in Patients Prescreened for C-kit/PDGFr Activated Pathways Using a Proteomic Based Assay
Status: Enrolling
Updated:  3/11/2014
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
New Individualized Therapy Trial for Metastatic Colorectal Cancer
A Phase I/II Study of Gleevec® Combined With Panitumumab (Vectibix®) in Patients Prescreened for C-kit/PDGFr Activated Pathways Using a Proteomic Based Assay
Status: Enrolling
Updated: 3/11/2014
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
Click here to add this to my saved trials
New Individualized Therapy Trial for Metastatic Colorectal Cancer
A Phase I/II Study of Gleevec® Combined With Panitumumab (Vectibix®) in Patients Prescreened for C-kit/PDGFr Activated Pathways Using a Proteomic Based Assay
Status: Enrolling
Updated:  3/11/2014
Inova Fairfax Hospital Department of Surgery
mi
from
Falls Church, VA
New Individualized Therapy Trial for Metastatic Colorectal Cancer
A Phase I/II Study of Gleevec® Combined With Panitumumab (Vectibix®) in Patients Prescreened for C-kit/PDGFr Activated Pathways Using a Proteomic Based Assay
Status: Enrolling
Updated: 3/11/2014
Inova Fairfax Hospital Department of Surgery
mi
from
Falls Church, VA
Click here to add this to my saved trials
A Web-Based Physical Activity Intervention in Adolescent Survivors of Childhood Cancer
A Randomized Web-Based Physical Activity Intervention in Adolescent Survivors of Childhood Cancer
Status: Enrolling
Updated:  3/12/2014
St. Jude Children's Research Hospital
mi
from
Memphis, TN
A Web-Based Physical Activity Intervention in Adolescent Survivors of Childhood Cancer
A Randomized Web-Based Physical Activity Intervention in Adolescent Survivors of Childhood Cancer
Status: Enrolling
Updated: 3/12/2014
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Pectoral Nerve Blockade in Mastectomy
Improvement of Analgesia With Addition of Pectoral Nerve Block to Thoracic Paravertebral Blocks in Unilateral Total Simple Mastectomy
Status: Enrolling
Updated:  3/12/2014
The University of New Mexico Hospital
mi
from
Albuquerque, NM
Pectoral Nerve Blockade in Mastectomy
Improvement of Analgesia With Addition of Pectoral Nerve Block to Thoracic Paravertebral Blocks in Unilateral Total Simple Mastectomy
Status: Enrolling
Updated: 3/12/2014
The University of New Mexico Hospital
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma
A Phase I/II Study of IL-15 Administration Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen and Autologous Lymphocyte Transfer in Metastatic Melanoma
Status: Enrolling
Updated:  3/14/2014
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma
A Phase I/II Study of IL-15 Administration Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen and Autologous Lymphocyte Transfer in Metastatic Melanoma
Status: Enrolling
Updated: 3/14/2014
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
A Phase I/II, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR610 Given Weekly in Subjects With Solid Tumors
Status: Enrolling
Updated:  3/19/2014
Scottsdale Healthcare
mi
from
Scottsdale, AZ
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
A Phase I/II, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR610 Given Weekly in Subjects With Solid Tumors
Status: Enrolling
Updated: 3/19/2014
Scottsdale Healthcare
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
A Phase I/II, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR610 Given Weekly in Subjects With Solid Tumors
Status: Enrolling
Updated:  3/19/2014
City of Hope National Medical Center
mi
from
Duarte, CA
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
A Phase I/II, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR610 Given Weekly in Subjects With Solid Tumors
Status: Enrolling
Updated: 3/19/2014
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
A Phase I/II, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR610 Given Weekly in Subjects With Solid Tumors
Status: Enrolling
Updated:  3/19/2014
University of California at Los Angeles
mi
from
Los Angeles, CA
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
A Phase I/II, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR610 Given Weekly in Subjects With Solid Tumors
Status: Enrolling
Updated: 3/19/2014
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
A Phase I/II, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR610 Given Weekly in Subjects With Solid Tumors
Status: Enrolling
Updated:  3/19/2014
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
A Phase I/II, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR610 Given Weekly in Subjects With Solid Tumors
Status: Enrolling
Updated: 3/19/2014
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
A Phase I/II, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR610 Given Weekly in Subjects With Solid Tumors
Status: Enrolling
Updated:  3/19/2014
Robert H. Lurie Comprehensive Cancer Research Center
mi
from
Chicago, IL
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
A Phase I/II, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR610 Given Weekly in Subjects With Solid Tumors
Status: Enrolling
Updated: 3/19/2014
Robert H. Lurie Comprehensive Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
A Phase I/II, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR610 Given Weekly in Subjects With Solid Tumors
Status: Enrolling
Updated:  3/19/2014
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
A Phase I/II, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR610 Given Weekly in Subjects With Solid Tumors
Status: Enrolling
Updated: 3/19/2014
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
Click here to add this to my saved trials
Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C
A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C
Status: Enrolling
Updated:  3/19/2014
Massachusetts General Hospital
mi
from
Boston, MA
Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C
A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C
Status: Enrolling
Updated: 3/19/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C
A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C
Status: Enrolling
Updated:  3/19/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C
A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C
Status: Enrolling
Updated: 3/19/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C
A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C
Status: Enrolling
Updated:  3/19/2014
Dana-Farber Cancer Institute
mi
from
Boston, MA
Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C
A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C
Status: Enrolling
Updated: 3/19/2014
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
Baylor College of Medicine Dept of Oncology
mi
from
Houston, TX
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
Baylor College of Medicine Dept of Oncology
mi
from
Houston, TX
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5)
mi
from
San Antonio, TX
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5)
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
Cedars Sinai Medical Center SC
mi
from
Los Angeles, CA
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
Cedars Sinai Medical Center SC
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
H. Lee Moffitt Cancer Center & Research Institute H. Lee Moffitt SC
mi
from
Tampa, FL
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
H. Lee Moffitt Cancer Center & Research Institute H. Lee Moffitt SC
mi
from
Tampa, FL
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
Highlands Oncology Group Dept of Highlands Oncology Grp
mi
from
Fayetteville, AR
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
Highlands Oncology Group Dept of Highlands Oncology Grp
mi
from
Fayetteville, AR
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
Massachusetts General Hospital Mass General 2
mi
from
Boston, MA
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
Massachusetts General Hospital Mass General 2
mi
from
Boston, MA
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
Memorial Sloan Kettering Cancer Center Dept of Onc
mi
from
New York, NY
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
Memorial Sloan Kettering Cancer Center Dept of Onc
mi
from
New York, NY
Click here to add this to my saved trials